about
Immunotherapy in Multiple Myeloma Using Cancer-Testis AntigensLeigh syndrome associated with a novel mutation in the COX15 gene.Expression of Testis Specific Genes TSGA10, TEX101 and ODF3 in Breast Cancer.Lactobacilli Differentially Modulate mTOR and Wnt/ β-Catenin Pathways in Different Cancer Cell Lines.Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy.Cancer-testis genes as candidates for immunotherapy in breast cancer.Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.MAGE-A3: an immunogenic target used in clinical practice.Expression analysis of long non-coding ATB and its putative target in breast cancer.ANRIL Genetic Variants in Iranian Breast Cancer Patients.Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder.Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex.Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.Expression analysis of four long noncoding RNAs in breast cancer.Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of three cases from Iran.Comparative expression analysis of hypoxia-inducible factor-alpha and its natural occurring antisense in breast cancer tissues and adjacent noncancerous tissues.Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population.An Iranian family with azoospermia and premature ovarian insufficiency segregating NR5A1 mutation.A case report: Autosomal recessive microcephaly caused by a novel mutation in MCPH1 gene.The effect of stochasticity on repair of DNA double strand breaks throughout non-homologous end joining pathway.Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patients.Long non-coding RNA expression in bladder cancer.A bioinformatics approach for identification of miR-100 targets implicated in breast cancer.Ecotropic Viral Integration Site 5 (EVI5) variants are associated with multiple sclerosis in Iranian population.Long Non Coding RNA Expression Intersecting Cancer and Spermatogenesis: A Systematic ReviewEcotropic Viral Integration Site 5 (EVI5) expression analysis in multiple sclerosis patients.STAT5a and STAT6 gene expression levels in multiple sclerosis patients.Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy.Association study of the vesicular monoamine transporter 1 (VMAT1) gene with autism in an Iranian population.Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients.Comparative evaluation of probiotics effects on plasma glucose, lipid, and insulin levels in streptozotocin-induced diabetic rats.Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum disorder.Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.Expression analysis of cytokine coding genes in epileptic patients.Melanoma: a prototype of cancer-testis antigen-expressing malignancies.Vaccinia Related Kinase 2 (VRK2) expression in neurological disorders: schizophrenia, epilepsy and multiple sclerosis.FOXP3 gene variations and susceptibility to autism: A case-control study.Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia
P50
Q26774913-9DDD17B3-9692-4F7E-BB9D-454ED703E2D8Q34517478-4F7DFF4D-3A47-4FA4-9D05-325992812937Q36576728-CF6C1E0E-FCE7-4426-B2E9-C87CC315110DQ37289324-693E3C20-50B0-4B07-9D02-36BD317756D2Q37965751-FA1C3514-9CC7-4901-B1F1-093601525C7AQ38184648-45379ED0-0946-4EAB-B1E6-477FAF40668DQ38242872-2EEB363A-4CFE-4C1A-9BF3-014C876D9B82Q38445350-6D4D33F0-F36A-4ACD-BE4B-460119B995C7Q38534721-66205B8E-34AD-4766-A8FF-B1ABE71C721FQ38672826-D584AC8B-59B4-482A-85CE-2FA0C34C88F8Q38674877-6C6E8E98-852C-461C-B90D-A9A1FBF3C52CQ38728392-3900BEC3-9A65-47B9-882E-BD7B146A4D60Q38731809-DAF5DB9A-DA1E-43EA-8104-52C973729A5EQ38754337-E951BDA8-4E7F-4474-BC4F-730B81F26794Q38832170-FC146A61-58A3-43F8-9639-761868992E5BQ38877309-00A46B07-DF0E-4C05-B7DF-89A27DE4739AQ39175378-8B397967-11C7-4FF0-B2E6-D4465520588EQ39906355-BA843CD8-BECE-4FFB-B262-9E944B46FBF0Q40308210-F73BADA3-292E-4B6B-AD75-7A92B98BEB76Q43560058-366005D1-D5A0-4D6F-8F97-833221586EB5Q43702973-9A59D52E-0E74-41CD-9E08-71383A1F948BQ47252922-456B5D61-5155-4960-BF4F-D37ABA543686Q47316985-D03A3E19-67B1-44B3-800D-92A29A33A5D2Q47339135-68C482A3-2F40-487D-910A-4BDECE2C77FCQ47448709-3D8E5261-B988-4ED6-B65B-8972F7A311B5Q47579227-79DA5C03-1D84-46C4-B946-3C091A56DA62Q47601811-C3DC4316-60B6-4529-B1E4-A6FD22CB629DQ47611011-EFCB4324-0852-4868-8CAE-B44F7585530CQ47845954-30CDD19D-20DA-4942-AF7A-9C3E1BE5B16EQ47876991-4DE4552F-EBB6-4F61-8EF4-DE5A7FF7498FQ47882822-F4906002-1FD3-422D-B855-C7DF3022580DQ47887903-C84A9E15-4016-47BF-8551-3A09FE15A9F1Q48285937-2F442988-2C77-4AF3-88E9-18B076C7BA98Q48312612-7872F11D-6168-4C05-A9A0-BFCB3D60E1F5Q50034618-208B57D6-8283-4462-9A93-8CC8757C125AQ50066767-212537A3-BA63-47CC-985D-765255BD26F4Q50070352-BF62BFF3-7E5F-4B7E-84AC-505828766797Q50183514-BD5879A8-D201-42DE-8237-6D59675C2607Q50313218-D2AFC67D-3A29-4984-9296-8B6DB15DD4CCQ50337384-F22EFC98-9A3E-45EE-8FA2-E44711D6567A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Soudeh Ghafouri-Fard
@ast
Soudeh Ghafouri-Fard
@en
Soudeh Ghafouri-Fard
@es
Soudeh Ghafouri-Fard
@nl
Soudeh Ghafouri-Fard
@sl
type
label
Soudeh Ghafouri-Fard
@ast
Soudeh Ghafouri-Fard
@en
Soudeh Ghafouri-Fard
@es
Soudeh Ghafouri-Fard
@nl
Soudeh Ghafouri-Fard
@sl
prefLabel
Soudeh Ghafouri-Fard
@ast
Soudeh Ghafouri-Fard
@en
Soudeh Ghafouri-Fard
@es
Soudeh Ghafouri-Fard
@nl
Soudeh Ghafouri-Fard
@sl
P106
P1153
55387443600
P31
P496
0000-0002-0223-499X